Cargando…
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics
SIMPLE SUMMARY: Glioblastoma is the most common and malignant primary brain tumor, with a median survival of around 14 months. The aggressiveness of glioblastoma is due to intense cell proliferation, angiogenesis, invasiveness, genetic instability, resistance to therapies and high frequency of relap...
Autores principales: | Guarnaccia, Laura, Navone, Stefania E., Masseroli, Matteo M., Balsamo, Melissa, Caroli, Manuela, Valtorta, Silvia, Moresco, Rosa M., Campanella, Rolando, Schisano, Luigi, Fiore, Giorgio, Galiano, Valentina, Garzia, Emanuele, Appiani, Giuseppe C., Locatelli, Marco, Riboni, Laura, Marfia, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946812/ https://www.ncbi.nlm.nih.gov/pubmed/35326565 http://dx.doi.org/10.3390/cancers14061412 |
Ejemplares similares
-
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
por: Guarnaccia, Laura, et al.
Publicado: (2021) -
Decreased serum level of sphingosine‐1‐phosphate: a novel predictor of clinical severity in COVID‐19
por: Marfia, Giovanni, et al.
Publicado: (2020) -
Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks
por: Riboni, Laura, et al.
Publicado: (2020) -
Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro‐oncology
por: Marfia, Giovanni, et al.
Publicado: (2022) -
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology
por: Campanella, Rolando, et al.
Publicado: (2020)